Transformational Power of Genomics in Pharma
Summary
Accelerating technologies within the genomics landscape
Several advancements in the pharmaceutical industry have enabled the field of genomics to expand, with researchers innovating new means of therapy for patients with a wide variety of diseases, subsequently enabling in-depth insights to be generated within the genomics landscape. Genomics therapies are paving the way for novel treatments that address the root cause of diseases, allowing additional resources to be allocated for efficient precision and personalized medicine therapies for the treatment of rare diseases with niche and low patient populations.
Scope
- A dedicated report examining the pivotal healthcare, technological, macroeconomic, and regulatory trends shaping the genomics field in pharma landscape. This report also provides an in-depth analysis of how these trends are poised to either accelerate progress or create obstacles for the growth of the genomics market.
- Understand the key trends accelerateing or hindering the genomics field in pharma space. See market forecasts for different therapies up to 2028. Understand recent and influential developments in genomics. Review of leaders and challengers across the genomics value chain.
- Executive summary
- Players
- Table Figure 1: Who are the leading players in the genomics space?
- Thematic Briefing
- Trends
- Healthcare trends
- Table Healthcare trends in the genomics space
- Technology trends
- Table Technology trends in the genomics space
- Macroeconomic trends
- Table Macroeconomic trends in the genomics space
- Regulatory trends
- Table Regulatory trends in the genomics space
- Healthcare trends
- Industry Analysis
- Market size and growth forecasts
- Table Figure 2: Global forecast sales of genomics-based medicine by key molecule type, 2024-2030
- Survey data
- GlobalData's genomics potential and impact on the pharma industry surveys, 2024-25
- Table Figure 3: Which of the following areas do you believe genomics has the most potential to impact the pharmaceutical
- Table Figure 4: Which emerging genomic technology do you believe will have the greatest impact on pharmaceutical
- Table Figure 5: What do you see as the biggest challenge in integrating genomics into pharmaceutical practices?
- GlobalData's genomics potential and impact on the pharma industry surveys, 2024-25
- Pharma case studies
- LPKF Laser & Electronics' CellShepherd can significantly improve singlecell analysis
- QIAGEN's two advanced tools aim to enhance microbial analysis
- Profluent develops OpenCRISPR-1, a GenAI-based gene editor
- Eligo Bioscience develops an undisruptive bacterial genome editing technology within the gut
- Market size and growth forecasts
- Signals
- M&A trends
- Table Examples of M&As in the genomics space, 2023-25
- Strategic partnerships
- Table Examples of strategic partnerships in the genomics space, 2023-25
- Funding deals
- Table Examples of funding deals in the genomics space, 2023-25
- Social media trends
- Table Figure 6: Top influencer trends related to genomics
- Table Figure 7: Top influencer posts related to genomics, 2025
- M&A trends
- Value Chain
- Table Figure 8: The genomics value chain
- Table Figure 9: Top companies for genomics drugs
- Next-generation sequencing
- Table Comparison of the different types of next-generation sequencing
- Table Figure 10: Examples of leaders and challengers in next-generation sequencing
- Bioinformatics
- Table Figure 11: Examples of leaders and challengers in bioinformatics
- Gene therapy
- Table Figure 12: Examples of leaders and challengers in gene therapy
- Table Figure 13: Top therapy areas within antisense oligonucleotides
- Companies
- Public companies
- Table Public companies
- Private companies
- Table Private companies
- Public companies
- Sector Scorecards
- Drug development sector scorecard
- Who's who
- Table Figure 14: Who does what in the drug development space?
- Thematic screen
- Table Figure 15: Thematic screen
- Valuation screen
- Table Figure 16: Valuation screen
- Risk screen
- Table Figure 17: Risk screen
- Who's who
- Drug development sector scorecard
- Bibliography
- Appendix
- Abbreviations
- Further Reading
- GlobalData reports
- Table GlobalData reports
- GlobalData reports
- Our Thematic Research Methodology
- Table Figure 18: Our five-step approach for generating a sector scorecard
- Table Thematic Scores
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook